tafamidis meglumine
pfizer
['pfizer']
join us at #acc2023 to learn more about a retrospective cohort study of elderly patients ( 65 years old) with #attrcm treated with #ttrstabilizer to better understand adherence rates in the real world #pfizermedical #amyloidosis 
Communicating emerging, trusted scientific information to healthcare professionals (HCPs). Pfizer sponsored, intended for U.S. HCPs. https://t.co/s5bPfuTvDc